The 120th Annual Meeting of the Japanese Society of Psychiatry and Neurology 2024.6.20-24 Sapporo Convention Center/Sapporo Business Innovation Center

Call for Papers

Call for Papers

Abstract submission period: 10:00 am, September 27 (Wed) – 12:00 pm, November 29 (Wed)
12:00 pm, December 7 (Thu), (Japan Standard Time, UTC+9)

Call for Papers has been closed. Thank you for your submission.
Notification of acceptance or rejection will be sent via email in March

Type of Presentation

The author can choose a preferred type of presentation. Please be adviced that the Program Committee will make the final decision on the type of presentations regardless of your preference.

  • Oral Presentation
  • Poster Presentation
  • Either will be fine

Abstract submission guidelines

  1. Once the submission is completed, a confirmation e-mail will be sent automatically. If you do not receive the confirmation e-mail within 24 hours after submission, please contact the Congress Secretariat (E-mail: abs-jspn120@c-linkage.co.jp).
  2. For any changes, withdrawal or additional submission, please contact the Congress Secretariat (E-mail: abs-jspn120@c-linkage.co.jp).

Submission Guideline

Title: up to 100 characters in single byte
Body of abstract: up to 300 words in single byte
Co-authors: up to 30 persons
Affiliations: up to 10 affiliations

Categories

Please choose the category for your paper.
*Up to 3 categories can be registered.
*You are required to choose at least 1 category.

1Schizophrenia and related disorders2Mood disorders
3Neurotic disorders and related disorders4Personality disorders
5Epilepsy6Dementia
7Behavioural syndromes associated with physiological disturbances and physical factors8Organic and symptomatic mental disorders
9Substance abuse and dependence10Mental disorders in childhood and adolescence
11Perinatal menal health12Sleep disorders
13Mental retardation14Mental disorders in old age
15Gender and mental health16Forensic psychiatry
17Forensic psychiatry18Medical education
19Psychopathology20Neuropsychology
21Neurophysiology22Psychopharmacology
23Neurochemistry24Neuropathology
25Genetics and molecular genetics26Epidemiology
27Community mental health services28Emergency psychiatry
29Consultation-liaison psychiatry30Psychiatric diagnosis
31Symptomatology32Pharmacotherapy
33Psychotherapy34Psychosocial therapy/psychoeducation
35ECT/TMS/neuromodulation36Laboratory tests/biomarkers
37Neuroimaging38Animal model/basic research
39Suicide prevention40Occupational mental health
41Social psychiatry42COVID-19
43AI44Treatment-refractory severe mental disorders
45Others
1Schizophrenia and related disorders
2Mood disorders
3Neurotic disorders and related disorders
4Personality disorders
5Epilepsy
6Dementia
7Behavioural syndromes associated with physiological disturbances and physical factors
8Organic and symptomatic mental disorders
9Substance abuse and dependence
10Mental disorders in childhood and adolescence
11周産期精神障害
12Sleep disorders
13Mental retardation
14Mental disorders in old age
15ジェンダーと精神医学
16Forensic psychiatry
17Forensic psychiatry
18Medical education
19Psychopathology
20Neuropsychology
21Neurophysiology
22Psychopharmacology
23Neurochemistry
24Neuropathology
25Genetics and molecular genetics
26Epidemiology
27Community mental health services
28Emergency psychiatry
29Consultation-liaison psychiatry
30Psychiatric diagnosis
31Symptomatology
32Pharmacotherapy
33Psychotherapy
34Psychosocial therapy/psychoeducation
35ECT/TMS/neuromodulation
36Laboratory tests/biomarkers
37Neuroimaging
38Animal model/basic research
39Suicide prevention
40Occupational mental health
41Social psychiatry
42COVID-19
43AI
44Treatment-refractory severe mental disorders
45Others

Personal Information Protection

Please read and agree to the "Handling of personal information" in the form.

Abstract Submission

Please download the form, answer the questions, and submit it to the Congress Secretariat by e-mail.

Submission Form_Ethical Considerations
JP EN